สัญลักษณ์ | YTM % | ปริมาณการซื้อขาย | ราคา % | ดอกเบี้ย % | วันครบกำหนดอายุ | ยอดคงค้าง | มูลค่าหน้าตั๋ว | จำนวนเงินขั้นต่ำ | ผู้ออก |
---|---|---|---|---|---|---|---|---|---|
15.37% | 181 K | 99.75% | 3.80% | 2025-03-15 | 2.89 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
AA5QDALLERGAN FNDG 15/25 | 8.83% | 0 | 99.89% | 3.80% | 2025-03-15 | 130.22 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 8.14% | 50 K | 74.10% | 4.75% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7.69% | 15 K | 77.85% | 4.85% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7.23% | 134 K | 79.81% | 4.63% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6.31% | 750 K | 89.19% | 4.55% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
5.86% | 6.79 M | 83.72% | 4.25% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.79% | 571 K | 90.85% | 4.88% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.74% | 26 K | 90.47% | 3.20% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.73% | 0 | 87.77% | 4.45% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.71% | 7.96 M | 88.48% | 4.40% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.70% | 1.49 M | 91.12% | 4.75% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.65% | 0 | 91.08% | 4.70% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.63% | 158 K | 92.75% | 4.85% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.59% | 36 K | 91.45% | 4.63% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.58% | 15.31 M | 87.62% | 4.05% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.57% | 13.28 M | 99.12% | 5.50% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.48% | 40.83 M | 99.07% | 5.40% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.45% | 5.35 M | 101.71% | 5.60% | 2055-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.41% | 4.52 M | 99.40% | 5.35% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.28% | 0 | 99.69% | 3.60% | 2025-05-14 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.19% | 0 | 93.68% | 4.30% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.14% | 1.71 M | 96.07% | 4.55% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.07% | 0 | 96.15% | 4.50% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.02% | 4.53 M | 101.22% | 5.20% | 2035-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.95% | 10.49 M | 100.60% | 5.05% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.74% | 28.21 M | 94.08% | 3.20% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.71% | 14.93 M | 101.11% | 4.95% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.66% | 3.17 M | 100.89% | 4.88% | 2030-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.54% | 3.03 M | 100.90% | 4.80% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.46% | 2.08 M | 100.50% | 4.65% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.45% | 4.98 M | 99.38% | 4.25% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.40% | 20.06 M | 97.69% | 2.95% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.36% | 8.9 M | 100.82% | 4.80% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.36% | 0 | 98.70% | 3.20% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
XXS162262122ALLERGAN FNDG 17/29 | 4.11% | 0 | 92.84% | 2.13% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
4.09% | 0 | 95.31% | 2.63% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS | |
3.86% | 0 | 96.53% | 2.95% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
3.27% | 0 | 88.87% | 1.25% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
3.01% | 0 | 102.15% | 3.80% | 2025-03-15 | 1.27 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
3.01% | 0 | 96.68% | 2.13% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.90% | 0 | 121.31% | 4.25% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.89% | 0 | 99.10% | 2.63% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.88% | 0 | 126.76% | 4.75% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.84% | 0 | 97.61% | 2.13% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.83% | 0 | 128.71% | 4.85% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.78% | 0 | 94.89% | 0.75% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.35% | 0 | 123.74% | 4.55% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
— | — | — | 3.80% | 2025-03-15 | — | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
— | — | — | 4.40% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |